[
    [
        {
            "time": "",
            "orginal_text": "创新药三季度报告：创新力量集中于头部企业，全球首创新药取得突破，肿瘤药扎堆存风险",
            "features": {
                "keywords": [
                    "创新药",
                    "三季度报告",
                    "头部企业",
                    "全球首创",
                    "肿瘤药",
                    "风险"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "创新药三季度报告：创新力量集中于头部企业，全球首创新药取得突破，肿瘤药扎堆存风险",
            "scores": {
                "News_content": "创新药三季度报告：创新力量集中于头部企业，全球首创新药取得突破，肿瘤药扎堆存风险",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业周报-三季报前瞻：整体乐观 强者恒强",
            "features": {
                "keywords": [
                    "医药生物",
                    "周报",
                    "三季报前瞻",
                    "整体乐观",
                    "强者恒强"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业周报-三季报前瞻：整体乐观 强者恒强",
            "scores": {
                "News_content": "医药生物行业周报-三季报前瞻：整体乐观 强者恒强",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医疗保健专题报告：医药行业2020年三季报业绩前瞻",
            "features": {
                "keywords": [
                    "医疗保健",
                    "专题报告",
                    "医药行业",
                    "2020年",
                    "三季报",
                    "业绩前瞻"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "保健"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医疗保健专题报告：医药行业2020年三季报业绩前瞻",
            "scores": {
                "News_content": "医疗保健专题报告：医药行业2020年三季报业绩前瞻",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]